287 related articles for article (PubMed ID: 9773480)
1. p-ANCA target antigens in ulcerative colitis.
Folwaczny C; Jochum M; Noehl N; Schnettler D; Loeschke K; Fricke H
Z Gastroenterol; 1998 Aug; 36(8):625-33. PubMed ID: 9773480
[TBL] [Abstract][Full Text] [Related]
2. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
[TBL] [Abstract][Full Text] [Related]
3. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.
Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K
Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role.
Kull K; Salupere R; Uibo R; Ots M; Salupere V
Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic autoantibodies in patients with systemic lupus erythematosus recognize a novel 69 kDa target antigen of neutrophil granules.
Chen M; Zhao MH; Zhang YK; Wang HY
Nephrology (Carlton); 2005 Oct; 10(5):491-5. PubMed ID: 16221101
[TBL] [Abstract][Full Text] [Related]
6. Incidence and studies on antigenic specificities of antineutrophil-cytoplasmic autoantibodies (ANCA) in poststreptococcal glomerulonephritis.
Ardiles LG; Valderrama G; Moya P; Mezzano SA
Clin Nephrol; 1997 Jan; 47(1):1-5. PubMed ID: 9021233
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between HLA-DRB1 alleles of the major histocompatibility complex and p-ANCA status or clinical characteristics in patients with ulcerative colitis.
Folwaczny C; Zahn R; Brünnler G; Albert E; Koenig A; Noehl N; Loeschke K; Fricke H
Z Gastroenterol; 1999 Feb; 37(2):133-40. PubMed ID: 10190246
[TBL] [Abstract][Full Text] [Related]
8. DNA-bound lactoferrin is the major target for antineutrophil perinuclear cytoplasmic antibodies in ulcerative colitis.
Teegen B; Niemann S; Probst C; Schlumberger W; Stöcker W; Komorowski L
Ann N Y Acad Sci; 2009 Sep; 1173():161-5. PubMed ID: 19758145
[TBL] [Abstract][Full Text] [Related]
9. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease?
Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718
[TBL] [Abstract][Full Text] [Related]
10. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease.
Walmsley RS; Zhao MH; Hamilton MI; Brownlee A; Chapman P; Pounder RE; Wakefield AJ; Lockwood CM
Gut; 1997 Jan; 40(1):105-9. PubMed ID: 9155585
[TBL] [Abstract][Full Text] [Related]
12. [Significance of the determination of antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis and Crohn's disease].
García-Herola A; Nos P; Hoyos M; Hinojosa J; Molés JR; Pascual S; Bustamante M; Sánchez Cuenca JM; Carmona E; Ponce J; Berenguer J
Gastroenterol Hepatol; 1998 Apr; 21(4):169-73. PubMed ID: 9633176
[TBL] [Abstract][Full Text] [Related]
13. Factors related to the presence of IgA class antineutrophil cytoplasmic antibodies in ulcerative colitis.
Esteve M; Mallolas J; Klaassen J; Abad-Lacruz A; Gonzàlez-Huix F; Cabré E; Fernández-Bañares F; Menacho M; Condom E; Martí-Ragué J; Gassull MA
Am J Gastroenterol; 1998 Apr; 93(4):615-8. PubMed ID: 9580546
[TBL] [Abstract][Full Text] [Related]
14. [Antineutrophil cytoplasmic antibodies in chronic inflammatory bowel diseases].
Schlenker T; Apenberg S; Raedsch R; Andrassy K; Plachky J; Kommerell B
Dtsch Med Wochenschr; 1992 Sep; 117(39):1463-8. PubMed ID: 1396127
[TBL] [Abstract][Full Text] [Related]
15. [antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].
Papo M; Quer JC; Pastor RM; García-Pardo G; Olona M; Prats E; Mirapeix E; Rodríguez R; Richart C
Med Clin (Barc); 1998 Jan; 110(1):11-5. PubMed ID: 9527980
[TBL] [Abstract][Full Text] [Related]
16. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.
Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission.
Lindgren S; Florén CH; Lindhagen T; Starck M; Stewenius J; Nässberger L
Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases.
Colombel JF; Reumaux D; Duthilleul P; Noël LH; Gower-Rousseau C; Paris JC; Cortot A
Gastroenterol Clin Biol; 1992; 16(8-9):656-60. PubMed ID: 1426820
[TBL] [Abstract][Full Text] [Related]
19. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role.
Hertervig E; Wieslander J; Johansson C; Wiik A; Nilsson A
Scand J Gastroenterol; 1995 Jul; 30(7):693-8. PubMed ID: 7481534
[TBL] [Abstract][Full Text] [Related]
20. [The diagnostic significance of antineutrophil cytoplasmic antibodies in ulcerative colitis].
Liu X; Yu T; Zhao M; Tang X; Gu Q; Liu N
Zhonghua Nei Ke Za Zhi; 1999 Jul; 38(7):451-4. PubMed ID: 11798679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]